Ambys Completes $47 Million Series A Extension To Advance Liver Cell Therapy Platform
Amount Raised
$47 Million
Round Type
Series A
San FranciscoSoftwareMobileAppsPlatformsDescription
Ambys Medicines, a company pioneering cell-based therapies for severe liver diseases, today announced it has completed a $47 million extension of its Series A financing. This brings the total Series A funding raised by Ambys to $107 million. Ambys is developing an entirely new approach to treating severe liver disease. The company's liver-cell production processes can produce, at scale, high-quality liver cells that function in vivo as normal healthy liver cells
Quick answer
Ambys Medicines raised $47 Million in a Series A round, dated December 21, 2021. Ambys Medicines is based in San Francisco, California, United States.
- How much did Ambys Medicines raise?
- Ambys Medicines raised $47 Million in a Series A round on December 21, 2021.
- What does Ambys Medicines do?
- Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease.
- Where is Ambys Medicines based and how big is it?
- Ambys Medicines is based in San Francisco, California, United States.
Source: Fundz verified event record.
Who else raised in Mobile and Apps around the same time
Companies in the same sectors as Ambys Medicines that raised within 45 days of this round, from Fundz verified event records.
- Sales Rabbit raised an undisclosed amount on December 21, 2021.
- Judo raised $3M (Seed) on November 18, 2021.
- Playtertainment raised $5M (Funding Round) on November 9, 2021.
- Digibee raised $25M (Series A) on February 3, 2022.
- Kaddra raised $2.5M (Seed) on January 27, 2022.
- Kaddra raised an undisclosed amount (Series A) on January 17, 2022.
Who to call at Ambys Medicines, and when
A new round usually means Ambys Medicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ambys Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ambys Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ambys Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ambys Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansAmbys Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.